Why earlier action could improve outcomes for people with atrial fibrillation

A Growing Healthcare Concern Across Asia Pacific

Atrial fibrillation (AFib) is a common heart rhythm disorder that can raise the risk of stroke, heart failure, and premature death. The number of people affected by AFib is expected to grow as populations age and cardiovascular risk factors such as hypertension, obesity, and diabetes continue to rise. In Asia Pacific, the prevalence of AFib is increasing, and it is becoming a significant healthcare concern.

The Importance of Early Diagnosis and Treatment

Earlier diagnosis and treatment of AFib can improve outcomes and quality of life for patients. Studies have shown that a shorter time between AFib diagnosis and catheter ablation – preferably within a year – is associated with greater procedural success and a lower risk of the condition recurring. However, many patients are typically referred for ablation only after multiple AFib recurrences, and fewer than half of eligible AFib patients are referred for ablation within a year of diagnosis.

The Potential of Pulsed Field Ablation

Pulsed field ablation (PFA) is a newer treatment option for AFib that uses short electrical pulses to target the heart tissue responsible for abnormal rhythms. Evidence suggests that PFA has shown effectiveness comparable to conventional thermal ablation, and it offers shorter procedure times and safety-related advantages linked to reduced effects on surrounding tissue. However, confidence in PFA is growing faster than its adoption, and many electrophysiologists are still hesitant to adopt this new technology.